Synopsis: Following the recent U.S. announcement of a one-time $100,000 fee for new H-1B visa applications, Mphasis Limited expects that no major impact on its operations or financials.
The IT company that delivers cloud and cognitive solutions, using advanced technology, is drawing attention as it expects its operations and finances to remain largely unaffected.
With a market capitalization of Rs.54,454.61 crore, the shares of Mphasis Limited are trading at Rs.2,865.80, down by 4.21 percent from the previous day’s closing price of Rs.2,991.70.
What’s the news?
Mphasis Limited expects no major impact on its operations or financials. With only about 130 new H-1B filings in 2025 and 78 approvals so far, the proportion of H-1B employees is relatively small. The company’s focus on AI-driven projects, local hiring, acquisitions, and partnerships has reduced dependence on visas. Operations will continue as usual, and the company remains fully staffed to meet client requirements while adapting to any challenges.
The company is a global IT solutions provider focused on cloud and cognitive services, using advanced technology to help businesses transform worldwide. Headquartered in Bengaluru, India, the Mphasis Group is a multicultural organization offering application development and maintenance, infrastructure outsourcing, and business and knowledge process outsourcing services to clients across the globe.
For Q1FY26, the company’s operating revenue rose to Rs.3,732 crore from Rs.3,422 crore in Q1FY25. Net profit also grew to Rs.442 crore compared to Rs.405 crore a year earlier. The return on equity is 18.2 percent, and the return on capital employed is 22.7 percent. In continuation, the stock is trading at a P/E of 31.37 with an industry average of 29.96.
Written By Jhanavi Sivakumar
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
